Chi Advisors LLC Purchases in Q3 2023

Chi Advisors LLC

Stock	Shares change	Price Range	Shares Held
BPMC Blueprint Medicines Corp Healthcare	92.9K New	$46.9 - $66.0 $4.36M - $6.13M	92.9K $4.66M
RARE Ultragenyx Pharmaceutical Inc. Healthcare	130K + 152.94%	$34.92 - $46.66 $4.54M - $6.07M	215K $7.66M
MLTX Moon Lake Immunotherapeutics Healthcare	60K New	$48.35 - $61.26 $2.9M - $3.68M	60K $3.42M
Syros Pharmaceuticals Inc	532K + 69.31%	N/A	1.3M $0
Sagimet Biosciences Inc	349K New	N/A	349K $0
Orchard Therapeutics PLC	11.6M + 1529.62%	N/A	12.3M $0
Mineralys Therapeutics Inc	568K New	N/A	568K $0
Freeline Therapeutics Hldgs	65K + 299.95%	N/A	86.7K $0
INZY Inozyme Pharma, Inc. Healthcare	75K + 6.28%	$4.09 - $7.0 $307K - $525K	1.27M $5.33M
KROS Keros Therapeutics, Inc. Healthcare	5.52K + 1.37%	$31.57 - $43.02 $174K - $237K	408K $13M
IKNA Ikena Oncology, Inc. Healthcare	58.9K + 2.78%	$4.09 - $6.43 $241K - $379K	2.18M $9.44M
TSVT 2seventy Bio, Inc. Healthcare	150K + 17.61%	$3.14 - $11.2 $471K - $1.68M	1M $3.93M

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.